Showing results (351-360 of 442) with videos related to
Sort By:
Pageof 45
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 15, 2011
The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humansMadhav Thambisetty, Kathy A Gallardo, Jeih-San Liow, et al.Translational Oncology|March 7, 2022
Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinomaNonkululeko Z Malinga, Shalete C Siwele, Helen C Steel, et al.Schizophrenia Research|January 18, 2005
Childhood-onset schizophrenia: smooth pursuit eye-tracking dysfunction in family membersAlexandra Sporn, Deanna Greenstein, Nitin Gogtay, et al.The American Journal of Psychiatry|May 1, 1997
Three-dimensional cortical morphometry of the planum temporale in childhood-onset schizophreniaL K Jacobsen, J N Giedd, C Tanrikut, et al.The Lancet. Oncology|August 15, 2015
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trialsBernardo L Rapoport, Martin R Chasen, Cesare Gridelli, et al.Journal of Child and Adolescent Psychopharmacology|January 15, 2005
Stimulant drug treatment in childhood-onset schizophrenia with comorbid ADHD: an open-label case seriesJulia W Tossell, Deanna K Greenstein, Anna L Davidson, et al.Neurology|December 1, 1995
Sydenham's chorea: magnetic resonance imaging of the basal gangliaJ N Giedd, J L Rapoport, M J Kruesi, et al.Journal of Global Oncology|November 3, 2017
Ipilimumab in Pretreated Patients With Advanced Malignant Melanoma: Results of the South African Expanded-Access ProgramBernardo L Rapoport, Daniel A Vorobiof, Lydia M Dreosti, et al.Journal of the American Academy of Child and Adolescent Psychiatry|April 29, 1998
Childhood-onset schizophrenia: an open-label study of olanzapine in adolescentsS Kumra, L K Jacobsen, M Lenane, et al.Future Oncology (London, England)|October 21, 2022
GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancerHope S Rugo, Javier Cortes, Carlos H Barrios, et al.Pageof 45